Dentsply Sirona Provides Update On Byte Aligner Products

Reuters
2024.10.24 22:12

Dentsply Sirona has voluntarily suspended sales and marketing of its Byte Aligners and Impression Kits while reviewing regulatory requirements, in consultation with the FDA. The company anticipates third quarter 2024 net sales of approximately $ million and adjusted EPS between $0.49 and $0.51. It expects non-cash charges for goodwill impairment in Orthodontic Aligner Solutions and Implants & Prosthetic Solutions due to regulatory impacts and weakened demand. Further updates will follow as the company assesses its business strategy and financial results.

Oct 24 (Reuters) - DENTSPLY SIRONA Inc (XRAY.O) :

  • DENTSPLY SIRONA PROVIDES UPDATE ON BYTE ALIGNER PRODUCTS

  • VOLUNTARY SUSPENSION OF SALES AND MARKETING OF ITS BYTE ALIGNERS AND IMPRESSION KITS

  • VOLUNTARILY SUSPENDS SALES AND MARKETING OF BYTE ALIGNERS AND IMPRESSION KITS

  • CONDUCTS A REVIEW OF CERTAIN REGULATORY REQUIREMENTS RELATED TO BYTE ALIGNERS AND IMPRESSION KITS

  • CO’S DECISION WAS MADE IN CONSULTATION WITH U.S. FOOD AND DRUG ADMINISTRATION

  • DENTSPLY SIRONA: BEGUN TO ASSESS RESOURCES AT BYTE TO LEVERAGE AND/OR REDEPLOY INFRASTRUCTURE, TALENT, AND CAPABILITY ELSEWHERE IN BUSINESS

  • OUTLOOK Q3 ADJUSTED EPS BETWEEN $0.49 AND $0.51

  • Q3 EARNINGS PER SHARE VIEW $0.47 – LSEG IBES DATA

  • DENTSPLY SIRONA: EXPECTS TO RECORD NON-CASH CHARGES FOR IMPAIRMENT OF GOODWILL WITHIN RANGE OF $450 - $550 MILLION, NET OF TAX, PERTAINING TO TWO UNITS

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.